Infant Bacterial Therapeutics AB (CHIX:IBTBS) Cyclically Adjusted Book per Share: kr77.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:IBTBS Infant Bacterial Therapeutics AB CHIX:IBTBS
27 GF Score
Price kr109.00
! 1 Warning Sign
View Full Analysis

What is Infant Bacterial Therapeutics AB Cyclically Adjusted Book per Share?

Infant Bacterial Therapeutics AB CHIX:IBTBS 27 Cyclically Adjusted Book per Share is kr77.99 as of Mar. 2026. GuruFocus rates CHIX:IBTBS with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Infant Bacterial Therapeutics AB's adjusted book value per share for the three months ended in Mar. 2026 was kr6.130. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr77.99 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-21), Infant Bacterial Therapeutics AB's current stock price is kr109.00. Infant Bacterial Therapeutics AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr77.99. Infant Bacterial Therapeutics AB's Cyclically Adjusted PB Ratio of today is 1.40.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Infant Bacterial Therapeutics AB was 1.81. The lowest was 0.00. And the median was 0.00.


Infant Bacterial Therapeutics AB  (CHIX:IBTBs) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Infant Bacterial Therapeutics AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=109.00/77.99
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Infant Bacterial Therapeutics AB was 1.81. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Infant Bacterial Therapeutics AB Cyclically Adjusted Book per Share Related Terms


Infant Bacterial Therapeutics AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Infant Bacterial Therapeutics AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infant Bacterial Therapeutics AB Cyclically Adjusted Book per Share Chart

Infant Bacterial Therapeutics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 79.00

Infant Bacterial Therapeutics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 58.47 79.00 77.99

CHIX:IBTBS vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Infant Bacterial Therapeutics AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Infant Bacterial Therapeutics AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Infant Bacterial Therapeutics AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Infant Bacterial Therapeutics AB's Cyclically Adjusted PB Ratio falls into.


CHIX:IBTBS
27GF Score
Infant Bacterial Therapeutics AB CHIX:IBTBS
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Infant Bacterial Therapeutics AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Infant Bacterial Therapeutics AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.13/133.5600*133.5600
=6.130

Current CPI (Mar. 2026) = 133.5600.

Infant Bacterial Therapeutics AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 101.019 0.000
201609 0.000 101.138 0.000
201612 17.185 102.022 22.497
201703 0.000 102.022 0.000
201706 13.653 102.752 17.747
201709 12.904 103.279 16.687
201712 22.901 103.793 29.469
201803 52.481 103.962 67.422
201806 52.540 104.875 66.911
201809 51.742 105.679 65.393
201812 49.592 105.912 62.538
201903 49.531 105.886 62.476
201906 48.857 106.742 61.132
201909 46.357 107.214 57.749
201912 45.466 107.766 56.348
202003 45.571 106.563 57.116
202006 43.083 107.498 53.528
202009 41.427 107.635 51.405
202012 39.208 108.296 48.355
202103 39.256 108.360 48.386
202106 36.658 108.928 44.948
202109 36.653 110.338 44.367
202112 35.209 112.486 41.805
202203 33.498 114.825 38.964
202206 33.815 118.384 38.150
202209 33.122 122.296 36.173
202212 29.548 126.365 31.230
202303 27.547 127.042 28.960
202306 20.854 129.407 21.523
202309 25.688 130.224 26.346
202312 22.653 131.912 22.936
202403 20.588 132.205 20.799
202406 17.570 132.716 17.682
202409 15.146 132.304 15.290
202412 12.639 132.987 12.693
202503 11.397 132.825 11.460
202506 9.973 133.699 9.963
202509 9.232 133.480 9.238
202512 7.819 133.390 7.829
202603 6.130 133.560 6.130

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr77.99 mean?
Infant Bacterial Therapeutics AB (CHIX:IBTBS) has a Cyclically Adjusted Book per Share of kr77.99 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Infant Bacterial Therapeutics AB and its competitors.
Is Infant Bacterial Therapeutics AB's Cyclically Adjusted Book per Share too high?
Infant Bacterial Therapeutics AB's current Cyclically Adjusted Book per Share is kr77.99. Overall, Infant Bacterial Therapeutics AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Infant Bacterial Therapeutics AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Infant Bacterial Therapeutics AB's Cyclically Adjusted Book per Share of kr77.99 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Infant Bacterial Therapeutics AB and its competitors. Infant Bacterial Therapeutics AB's current Cyclically Adjusted Book per Share is kr77.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infant Bacterial Therapeutics AB stock overvalued right now?
Infant Bacterial Therapeutics AB (CHIX:IBTBS) has a current Cyclically Adjusted Book per Share of kr77.99. The current Cyclically Adjusted Book per Share is kr77.99. Infant Bacterial Therapeutics AB's overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Infant Bacterial Therapeutics AB (CHIX:IBTBS), the current Cyclically Adjusted Book per Share is kr77.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Infant Bacterial Therapeutics AB Business Description

Other Exchanges IBT B:Sweden9IB:Germany
Address Katarina Bangata 70, Stockholm, SWE, 116 42
Infant Bacterial Therapeutics AB is a pharmaceutical company. Its purpose is to develop and commercialize drugs for diseases affecting premature babies. Its focus is on the drug candidate IBP-9414, whose development program is designed to show a reduced incidence of necrotizing enterocolitis (NEC) and improved gastrointestinal function (SFT) when treated with IBP-9414's active substance, Lactobacillus reuteri bacterial strain naturally found in human breast milk. Its portfolio also includes additional drug candidates, IBP-1016, IBP-1118, and IBP-1122. IBP1016, for the treatment of gastroschisis, is a life-threatening and rare disorder in which children are born with externalized gastrointestinal organs.
27GF Score

Get the complete analysis for CHIX:IBTBS

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr109.00
Price